TP53 and carcinoma: In the oldest patient included in this study, cellular responses to stimuli and programmed cell death pathways were related to the TP53 gene, a tumor suppressor affected in up to 60% of sporadic CRC patients and related to the classical adenoma–carcinoma sequence.